The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expression

Genes Chromosomes and Cancer

Volumn 50, Issue 12, 2011, Pages 1033-1042

  Nettersheim, Daniel ^a   Gillis, Ad ^b   Biermann, Katharina ^b   Looijenga, Leendert H J ^b   Schorle, Hubert ^a  

^a UNIVERSITY OF BONN   (Germany)

^b JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DEPSIPEPTIDE; HISTONE DEACETYLASE INHIBITOR; OCTAMER TRANSCRIPTION FACTOR 4; RETINOIC ACID; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX17;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN TISSUE; PRIMORDIAL GERM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEMINOMA;

APOPTOSIS; AZACITIDINE; CELL DIFFERENTIATION; CELL LINE, TUMOR; DEPSIPEPTIDES; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; ENDODERM; GENE KNOCKDOWN TECHNIQUES; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HOMEODOMAIN PROTEINS; HUMANS; MALE; OCTAMER TRANSCRIPTION FACTOR-3; SEMINOMA; SOXF TRANSCRIPTION FACTORS; TESTICULAR NEOPLASMS; TRANSCRIPTION FACTOR AP-2; TRANYLCYPROMINE; TRETINOIN; UP-REGULATION;

EID: 80053653964     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20918     Document Type: Article

References (31)

1. Ancelin K, Lange UC, Hajkova P, Schneider R, Bannister AJ, Kouzarides T, Surani MA. 2006. Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells. Nat Cell Biol 8: 623-630.
2. Battifora H, Sheibani K, Tubbs RR, Kopinski MI, Sun TT. 1984. Antikeratin antibodies in tumor diagnosis. Distinction between seminoma and embryonal carcinoma. Cancer 54: 843-848.
3. Byrd JC, Shinn C, Ravi R, Willis CR, Waselenko JK, Flinn IW, Dawson NA, Grever MR. 1999. Depsipeptide (FR901228): A novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells. Blood 94: 1401-1408.
4. Chai G, Li L, Zhou W, Wu L, Zhao Y, Wang D, Lu S, Yu Y, Wang H, McNutt MA, Hu YG, Chen Y, Yang Y, Wu X, Otterson GA, Zhu WG. 2008. HDAC inhibitors act with 5-aza-2'-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells. PLoS One 3: e2445.
5. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, Smith A. 2003. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113: 643-655.
6. Czaja JT, Ulbright TM. 1992. Evidence for the transformation of seminoma to yolk sac tumor, with histogenetic considerations. Am J Clin Pathol 97: 468-477.
7. Damjanov I, Horvat B, Gibas Z. 1993. Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT. Lab Invest 68: 220-232.
8. de Jong J, Stoop H, Gillis AJ, Hersmus R, van Gurp RJ, van de Geijn GJ, van Drunen E, Beverloo HB, Schneider DT, Sherlock JK, Baeten J, Kitazawa S, van Zoelen EJ, van Roozendaal K, Oosterhuis JW, Looijenga LH. 2008a. Further characterization of the first seminoma cell line TCam-2. Genes Chromosomes Cancer 47: 185-196.
9. de Jong J, Stoop H, Gillis AJ, van Gurp RJ, van de Geijn GJ, Boer M, Hersmus R, Saunders PT, Anderson RA, Oosterhuis JW, Looijenga LH. 2008b. Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implications. J Pathol 215: 21-30.
10. Deb-Rinker P, Ly D, Jezierski A, Sikorska M, Walker PR. 2005. Sequential DNA methylation of the Nanog and Oct-4 upstream regions in human NT2 cells during neuronal differentiation. J Biol Chem 280: 6257-6260.
11. Eckert D, Nettersheim D, Heukamp LC, Kitazawa S, Biermann K, Schorle H. 2008. TCam-2 but not JKT-1 cells resemble seminoma in cell culture. Cell Tissue Res 331: 529-538.
12. Fabiani E, Leone G, Giachelia M, D'Alo F, Greco M, Criscuolo M, Guidi F, Rutella S, Hohaus S, Voso MT. 2010. Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. Leuk Lymphoma 51: 2275-2284.
13. Ghoshal K, Datta J, Majumder S, Bai S, Kutay H, Motiwala T, Jacob ST. 2005. 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal. Mol Cell Biol 25: 4727-4741.
14. Guan K, Chang H, Rolletschek A, Wobus AM. 2001. Embryonic stem cell-derived neurogenesis. Retinoic acid induction and lineage selection of neuronal cells. Cell Tissue Res 305: 171-176.
15. Hyslop L, Stojkovic M, Armstrong L, Walter T, Stojkovic P, Przyborski S, Herbert M, Murdoch A, Strachan T, Lako M. 2005. Downregulation of NANOG induces differentiation of human embryonic stem cells to extraembryonic lineages. Stem Cells 23: 1035-1043.
16. Lim S, Janzer A, Becker A, Zimmer A, Schule R, Buettner R, Kirfel J. 2010. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 31: 512-520.
17. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M, Yamanaka S. 2003. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113: 631-642.
18. Mongan NP, Gudas LJ. 2007. Diverse actions of retinoid receptors in cancer prevention and treatment. Differentiation 75: 853-870.
19. Monneret C. 2005. Histone deacetylase inhibitors. Eur J Med Chem 40: 1-13.
20. Oosterhuis JW, Looijenga LH. 2005. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5: 210-222.
21. Pan G, Thomson JA. 2007. Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res 17: 42-49.
22. Salem CE, Markl ID, Bender CM, Gonzales FA, Jones PA, Liang G. 2000. PAX6 methylation and ectopic expression in human tumor cells. Int J Cancer 87: 179-185.
23. Schulte JH, Lim S, Schramm A, Friedrichs N, Koster J, Versteeg R, Ora I, Pajtler K, Klein-Hitpass L, Kuhfittig-Kulle S, Metzger E, Schule R, Eggert A, Buettner R, Kirfel J. 2009. Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: Implications for therapy. Cancer Res 69: 2065-2071.
24. Srigley JR, Mackay B, Toth P, Ayala A. 1988. The ultrastructure and histogenesis of male germ neoplasia with emphasis on seminoma with early carcinomatous features. Ultrastruct Pathol 12: 67-86.
25. Strickland S, Mahdavi V. 1978. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 15: 393-403.
26. Thiagalingam S, Cheng KH, Lee HJ, Mineva N, Thiagalingam A, Ponte JF. 2003. Histone deacetylases: Unique players in shaping the epigenetic histone code. Ann N Y Acad Sci 983: 84-100.
27. Ueda H, Manda T, Matsumoto S, Mukumoto S, Nishigaki F, Kawamura I, Shimomura K. 1994. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. III. Antitumor activities on experimental tumors in mice. J Antibiot (Tokyo) 47: 315-323.
28. Weber S, Eckert D, Nettersheim D, Gillis AJ, Schafer S, Kuckenberg P, Ehlermann J, Werling U, Biermann K, Looijenga LH, Schorle H. 2010. Critical function of AP-2 gamma/TCFAP2C in mouse embryonic germ cell maintenance. Biol Reprod 82: 214-223.
29. Wobus AM, Kaomei G, Shan J, Wellner MC, Rohwedel J, Ji G, Fleischmann B, Katus HA, Hescheler J, Franz WM. 1997. Retinoic acid accelerates embryonic stem cell-derived cardiac differentiation and enhances development of ventricular cardiomyocytes. J Mol Cell Cardiol 29: 1525-1539.
30. You JS, Kang JK, Seo DW, Park JH, Park JW, Lee JC, Jeon YJ, Cho EJ, Han JW. 2009. Depletion of embryonic stem cell signature by histone deacetylase inhibitor in NCCIT cells: Involvement of Nanog suppression. Cancer Res 69: 5716-5725.
31. Zhang B, Huang T, Liu K, Chen J, Wang G. 2007. Effects of 5-Aza-CdR on cell proliferation of breast cancer cell line MDA-MB-435S and expression of maspin gene. J Huazhong Univ Sci Technol Med Sci 27: 543-546.